Total Payments
$2,536
2024 Payments
$1,628
Companies
18
Transactions
72
Medicare Patients
1,027
Medicare Billing
$42,976
Payment Breakdown by Category
Food & Beverage$2,503 (98.7%)
Education$32.27 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,503 | 71 | 98.7% |
| Education | $32.27 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $520.53 | 18 | $0 (2024) |
| Amgen Inc. | $374.69 | 11 | $0 (2024) |
| ABBVIE INC. | $264.34 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $241.63 | 7 | $0 (2024) |
| Lilly USA, LLC | $234.57 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $149.68 | 1 | $0 (2022) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $148.75 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $147.33 | 2 | $0 (2023) |
| Inspire Medical Systems, Inc. | $122.94 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $119.52 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,628 | 54 | Novo Nordisk Inc ($328.80) |
| 2023 | $757.98 | 17 | Novo Nordisk Inc ($191.73) |
| 2022 | $149.68 | 1 | Janssen Pharmaceuticals, Inc ($149.68) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $122.94 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: VACCINES | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: VACCINES | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $109.01 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.94 | General |
| 06/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Inflammation | ||||||
| 06/04/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 195 | 215 | $33,946 | $13,961 |
| 2022 | 6 | 495 | 603 | $72,703 | $9,921 |
| 2021 | 4 | 176 | 197 | $65,565 | $11,754 |
| 2020 | 6 | 161 | 186 | $40,708 | $7,340 |
Total Patients
1,027
Total Services
1,201
Medicare Billing
$42,976
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $8,202 | $3,731 | 45.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 41 | $9,676 | $3,499 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 53 | $8,427 | $3,228 | 38.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $1,656 | $1,506 | 91.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 42 | $4,244 | $1,256 | 29.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $1,740 | $740.35 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 132 | $39,732 | $5,761 | 14.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 37 | $15,688 | $1,734 | 11.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 321 | 398 | $8,358 | $1,173 | 14.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 11 | $7,513 | $660.45 | 8.8% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 14 | 14 | $840.00 | $486.99 | 58.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 11 | $572.00 | $105.95 | 18.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 78 | $33,618 | $5,687 | 16.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 76 | $23,028 | $4,228 | 18.4% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 11 | 12 | $8,268 | $1,746 | 21.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 31 | 31 | $651.00 | $93.00 | 14.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 76 | 95 | $32,870 | $5,679 | 17.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 26 | $6,188 | $975.88 | 15.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 11 | $330.00 | $330.00 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 14 | 14 | $420.00 | $244.86 | 58.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 25 | 28 | $588.00 | $84.00 | 14.3% |
| 81003 | Automated urinalysis test | Office | 2020 | 11 | 12 | $312.00 | $26.75 | 8.6% |
About Veronica Tiburcio-Espinoza, PA-C
Veronica Tiburcio-Espinoza, PA-C is a Physician Assistant healthcare provider based in Wilsonville, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1295983625.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Veronica Tiburcio-Espinoza, PA-C has received a total of $2,536 in payments from pharmaceutical and medical device companies, with $1,628 received in 2024. These payments were reported across 72 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,503).
As a Medicare-enrolled provider, Tiburcio-Espinoza has provided services to 1,027 Medicare beneficiaries, totaling 1,201 services with total Medicare billing of $42,976. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Wilsonville, OR
- Active Since 08/27/2008
- Last Updated 10/14/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1295983625
Products in Payments
- Ozempic (Drug) $292.36
- FARXIGA (Drug) $211.84
- MOUNJARO (Drug) $169.17
- XARELTO (Drug) $149.68
- CAPLYTA (Drug) $148.75
- CREON (Drug) $136.40
- Wegovy (Drug) $124.98
- INSPIRE (Device) $122.94
- EVENITY (Biological) $119.52
- SIMPONI ARIA (Biological) $119.52
- KRYSTEXXA (Biological) $96.13
- Repatha (Biological) $90.00
- Rybelsus (Drug) $85.25
- Otezla (Drug) $69.04
- JARDIANCE (Drug) $65.40
- UBRELVY (Drug) $54.89
- QULIPTA (Drug) $51.58
- REXULTI (Drug) $49.15
- SHINGRIX (Biological) $39.16
- XYOSTED (Drug) $32.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.